Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung disease

Respiration

Volumn 80, Issue 5, 2010, Pages 372-378

  Cui, Ai ^a,f   Anhenn, Olaf ^a,b   Theegarten, Dirk ^b   Ohshimo, Shinichiro ^a   Bonella, Francesco ^a   Sixt, Stephan U ^c   Peters, Juergen ^c   Sarria, Rafael ^e   Guzman, Josune ^d   Costabel, Ulrich ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Institute of Pathology and Neuropathology   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^f CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alveolar macrophage; Chemokine; Granulomatous lung disease; Idiopathic pulmonary fibrosis

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 18; INTERLEUKIN 8;

ADULT; AGED; ALLERGIC PNEUMONITIS; ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; LUNG GRANULOMA; LUNG LAVAGE; LUNG SARCOIDOSIS; MACROPHAGE; MALE; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL;

AGED; ALVEOLITIS, EXTRINSIC ALLERGIC; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CELLS, CULTURED; CHEMOKINE CXCL10; CHEMOKINE CXCL9; EOSINOPHILS; FEMALE; HUMANS; INTERLEUKIN-18; INTERLEUKIN-8; MALE; NEUTROPHILS; PULMONARY FIBROSIS; SARCOIDOSIS, PULMONARY;

EID: 77958060949     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000245332     Document Type: Article

References (32)

1. American Thoracic Society/European Respiratory Society: International multidisci-plinary consensus classification of idiopath-ic interstitial pneumonias: general principles and recommendations. Am J Respir Crit Care Med 2002; 165:277-304.
2. Newman LS, Wasfi YS: Sarcoidosis. Prog Respir Res 2007; 36: 128-138 .
3. Vogelmeier C: Hypersensitivity pneumoni-tis. Prog Respir Res 2007; 36:139-147.
4. Singer AJ, Clark RA: Cutaneous wound healing. N Engl J Med 1999; 341:738-746.
5. Michael PK, et al: ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 164:2239-2242.
6. Peao MND, et al: Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat Rec 1994; 238: 57-67.
7. Zlotnik A, Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity 2000; 12: 254-257.
8. Strieter RM, et al: The functional role of the ELR motif in CXC chemokine-mediated an-giogenesis. J Biol Chem 1995; 270:27348-27357.
9. Gerard C, Rollins BJ: Chemokines and disease. Nat Immunol 2001; 2: 108-115.
10. Gasperini S, et al: Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol 1999; 162: 4928-4937.
11. Coughlin CM, et al: Interleukin-12and in-terleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest 1998; 101: 1441-1452.
12. American Thoracic Society/European Respiratory Society: Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161:646-664.
13. Tong ZH, et al: Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline: comparison with dexamethasone. Chest 2003; 124: 1526-1532.
14. Fujimori Y, et al: The role of interleukin-8 in interstitial pneumonia. Respirology 2003; 8: 33-40.
15. Car BD, et al: Elevated IL-8 and MCP-1in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 1994; 149: 655-659.
16. Ziegenhagen MW, et al: Serum level of inter-leukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. Am J Respir Crit Care Med 1998; 157: 762-768.
17. Gadek JE, et al: Collagenase in the low respiratory tract of patients with idiopathic pulmonary fibrosis. N Engl J Med 1979; 301:737-742.
18. Hunninghake GW, Gadek JE, Lawley TJ: Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 1981; 68:259-269.
19. Lynch JP 3rd, et al: Neutrophilic alveolitis in idiopathic pulmonary fibrosis: the role of interleukin-8. Am Rev Respir Dis 1992; 145: 1433-1143.
20. Takeuchi M, et al: Elevated serum levels of CXCL9/monokine induced by interferon-7and CXCL10/interferon-7-inducible pro-tein-10 in ocular sarcoidosis. Invest Oph-thalmo Vis Sci 2006; 47: 1063-1068.
21. Nance S, Cross R, Fitzpatrick E: Chemokine production during hypersensitivity pneumonitis. Eur J Immunol 2004; 34:677-685.
22. Antoniou KM, et al: Different angiogenic activity in pulmonary sarcoidosis and idio-pathic pulmonary fibrosis. Chest 2006; 130: 982-988.
23. Miotto D, et al: Expression of IFN-gamma-inducible protein, monocyte chemotactic proteins 1, 3, and 4, and eotaxin in TH1-and TH2-mediated lung diseases. J Allergy Clin Immunol 2001; 10 7: 664-670.
24. Agostini C, et al: Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J Immunol 1998; 161: 6413-6420.
25. Strieter RM, et al: CXC chemokines in an-giogenesis. Cytokine Growth Factor Rev 2005; 16:593-609.
26. Keane MP, et al: The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in id-iopathic pulmonary fibrosis. J Immunol 1997; 159: 1437-1443.
27. Keane MP: Neutralization of the CXC che-mokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J Immunol 1999; 162: 5511-5518.
28. Keane MP: IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol 1999; 163:5686-5692.
29. Ebina M, et al: Heterogeneous increase in CD34-positive alveolar capillaries in idio-pathic pulmonary fibrosis. Am J Respir Crit Care Med 2004; 169:1203-1208.
30. Meyer KC, Cardoni A, Xiang ZZ: Vascular endothelial growth factor in brochoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J Lab Clin Med 2000; 135: 332-338.
31. Cosgrove GP, et al: Aberrant angiogenesis in idiopathic pulmonary fibrosis (abstract). Am J Respir Crit Care Med 2003; 167: A 300 .
32. Robert MS, John AB, Michael PK: CXC che-mokines in angiogenesis related to pulmonary fibrosis. Chest 2002; 122: 298-301.